Unidad de Investigación, Complejo Asistencial Universitario de León, Spain.
Immunobiology. 2012 Apr;217(4):394-401. doi: 10.1016/j.imbio.2011.10.015. Epub 2011 Nov 3.
We have investigated the role of CXCL7 in the immune response of human phagocytes against the intracellular bacteria Mycobacterium tuberculosis and Legionella pneumophila. We have observed that polymorphonuclear neutrophil (PMN) chemotaxis induced by the supernatants of infected monocyte derived macrophages (MDM) may be attributed to CXCL8 rather than CXCL7, although both chemokines are present in large quantities. We have also found that CXCL7 is present not only in the supernatants of MDM, but also in the supernatants of PMN of some, but not all, individuals. Western blot analysis revealed that, in both MDM and PMN supernatants appeared two bands with molecular weights consistent with the platelet basic protein (PBP) and the neutrophil activating protein-2 (NAP-2) sizes. Regarding the influence on infected cells, recombinant NAP-2 enhanced the antimicrobial activity of IFNγ activated MDM against L. pneumophila, but not against M. tuberculosis. In addition, U937 cells transfected with a NAP-2 construct inhibited the intracellular multiplication of L. pneumophila, supporting its role in the modulation of the antimicrobial activity. Finally, U937 cells transfected with the NAP-2 construct showed an adherence that was dramatically enhanced when the substrate was fibronectin. We conclude that human phagocytes produce CXCL7 variants that may have a significant influence on the immune response against bacterial pathogens.
我们研究了 CXCL7 在人类吞噬细胞针对细胞内细菌结核分枝杆菌和嗜肺军团菌的免疫反应中的作用。我们观察到,感染的单核细胞衍生巨噬细胞(MDM)上清液诱导的多形核中性粒细胞(PMN)趋化作用可能归因于 CXCL8 而不是 CXCL7,尽管这两种趋化因子都大量存在。我们还发现,CXCL7 不仅存在于 MDM 的上清液中,而且存在于某些但不是所有个体的 PMN 的上清液中。Western blot 分析显示,在 MDM 和 PMN 的上清液中都出现了两条分子量与血小板碱性蛋白(PBP)和中性粒细胞激活蛋白-2(NAP-2)大小一致的带。关于对感染细胞的影响,重组 NAP-2 增强了 IFNγ 激活的 MDM 对嗜肺军团菌的抗菌活性,但对结核分枝杆菌没有影响。此外,转染 NAP-2 构建体的 U937 细胞抑制了嗜肺军团菌的细胞内增殖,支持其在调节抗菌活性中的作用。最后,转染 NAP-2 构建体的 U937 细胞表现出强烈增强的粘附性,当底物是纤维连接蛋白时。我们得出结论,人类吞噬细胞产生的 CXCL7 变体可能对针对细菌病原体的免疫反应有重大影响。